Go to ihpba.org
Browse Content
All the content on myHPB can be browsed and filtered by keyword tag. Click on a tag below to view all content in that area.
A-PHPBA Learn
ablation
Acute Cholecystitis
Acute pancreatitis
Adenoma
Adjuvant therapy
AGA
ALPPS
Ampullary adenocarcinoma
anaesthesia
Anatomic Hepatectomy
Anatomic Segmentectomy
Anatomical Hepatectomy
Anatomical Segmentectomy
anterior approach
Arterial and Venous Reconstruction
Ascites
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)
BDI
Benign
Benign Bile Duct Stricture
Bile duct
Bile duct injury
Bile duct resection
Biliary
Biliary Mapping
biology
biomarkers
Bleeding
Borderline Resectable Pancreatic Cancer
cancer
centralization
Chemotherapy
Chemotherapy
Children
Cholangiocarcinoma
cholecystectomy
Cholelithiasis
Chronic pancreatitis
Collagen
colon
Colorectal
Colorectal cancer
Colorectal liver metastases
Colorectal Liver Metastasis
Colorectal mets
Colorectal mets
Common Bile Duct
comorbidity
Complex Liver Cysts
Complicaitons
Consensus
Cost
COVID
COVID-19
Critical
Critical View of Safety
CRLM
CUSA
Cyst Gastrostomy
Cystic Duct
Cystic Pancreatic Lesions
Discussion type
Distal pancreatectomy
DNA/RNA
donor
drainage
Duodenal adenocarcinoma - outcomes
Duodenal sleeve resection
E-AHPBA Learn
EBM
Education
Embolization
Encephalopathy
Endoscopy
ERAS
ESPAC
european guidelines
european study group
EUS
Exercise Tolerance
Fibrin glue
Fistula minimally invasive approach
Floseal
Fluid management
fluid restriction
Fluorescence
Focal nodular hyperplasia
Functional liver remnant
Gall Bladder
Gallbladder
- Gallbladder
- Bile leak
- Biliary
- Central Hepatectomy
- Chemotherapy
- Cholecystectomy
- Cholecystocolic Fistula
- Cholecystostomy Tube
- Gall bladder
- Gallbladder Cancer
- Gallbladder Mass
- Gallbladder Polyp
- Intrahepatic Gallbladder
- Outcomes
- Pathology
- Portal Lymphadenectomy
- Posterior sectoral duct injury
- Quality of life
- Radiological imaging/intervention
- Radiotherapy
- Resection
- Surgical palliation
Gallbladder Cancer
General
- Ampullary adenoma
- auto-islet cell transplant
- Autoimmune cholangiopathy
- Chemo-radiation
- Cholecystitis
- Choledocholithiasis
- Chronic pain
- Critical View of Safety
- Cystgastrostomy
- Duodenal adenoma
- Duodenal cancer
- Duodenectomy
- ERCP
- Extracorporeal shockwave
- Extrahepatic cholangiocarcinoma
- Familial adenomatous polyposis
- FAP (familial adenomatous polyposis)
- Frey procedure
- Gallbladder carcinoma
- Hepaticojejunostomy
- Laparoscopic
- Liver transplant
- Minimally Invasive
- MIPR
- Mirizzi’s Syndrome
- Necrotizing Pancreatitis
- nutrition optimization
- pancreatic lithotripsy
- Pancreaticoduodenectomy
- Pseudocyst
- Sphincterotomy
- Spy Glass
- WHO ladder
genetics
glycemic control
glycoproteins
guidelines
halsted
harmonic scalpel
HCC
Hemopatch
Hepatectomy
Hepatic adenoma
Hepatoblastoma
Hepatocellular Carcinoma
Hilar Cholangiocarcinoma
HVE
IAP
ICC
ICG
IHCA
ILLS
immunomodulatiors
implementation
Infected Pancreatic Necrosis
Innovation
Intrahepatic Cholangiocellular Carcinoma
IOUS
IPMN
Iscahmia reperfusion
islet transplantation
Lap Chole
Laparoscopic
Laparoscopic Cholecystectomy
Laparoscopic Liver Resection
Laparoscopic Liver Surgery
laparoscopic resection
Laparoscopy
Large HCC
LDLT
live donor
Liver
- Liver
- Adenoma
- Caudate Lobe
- Chemotherapy
- Cholangiocarcinoma
- Cirrhosis
- Colorectal Metastases
- Focal nodular hyperplasia
- Haemostasis
- Haemostat
- Hepatic Resection
- Hepatocellular carcinoma
- Left Hepatectomy
- liver failure
- Liver Resection
- Palliation
- partial hepatectomy
- Resection
- Right Hepatectomy
- Robotic surgery (Liver)
- small residual volume
- Transarterial chemoembolization (TACE)
Liver Adenoma
Liver Metastasis
Liver Mets
liver resection
Liver Transplant
Liver transplantation
Liver-directed therapy
Living donor
Localization
Locally Advanced Pancreatic Cancer
Main duct IPMN
Malnutrition
Marginal Live Donor
Mayo protocol
metastases
Metastasis
Metastatic Pancreas Adenocarcinoma
Milan criteria
Minimal Invasive Pancreas Resection
Minimally invasive
Minimally invasive pancreatectomy
miRNA
MIS
molecular pathology
multimodality
Negative Staining
Neoadjuvant Chemotherapy
Neoadjuvant therapy
Neuroendocrine tumor
Nutrition
observation
oncogenes
Open
Outcomes
Outreach Projects
Oxidized cellulose
Paediatric
Pancreas
Pancreas Anastomosis
Pancreas Cancer
Pancreas pancreatic fistula
Pancreatectomy
Pancreatectomy pancreatic resection
Pancreatic cancer
Pancreatic cyst
Pancreatic neck POPF
Pancreatic neck resection pancreatic head
Pancreatic neoplasia
- Pancreatic neoplasia
- Adenocarcinoma
- adenocarcinoma
- Chemotherapy
- Cystic tumours
- Intraductal
- mucinous
- Neuroendocrine tumors
- Neuroendocrine tumours
- Neuroendocrine tumours
- Outcomes
- papillary
- Peri-ampullary tumours
- Quality of life
- Radiological imaging
- Radiological imaging/intervention
- Radiological intervention
- Radiotherapy
- Resection
- Surgical palliation
Pancreatic Surgery
Pancreaticoduodenectomy
Pancreatoduodenectomy
Parenchyma
PCLD
perioperative care
Peripancreatic Fluid Collection
Polypectomy
POPF
port placement
Portal vein embolization
Positive Staining
Post-operative dysfuntion
Postoperative pancreatic fistula
preoperative carbohydrate load
presidential adress
Pringle manuever
proteomics
PVE
R0 Resection
Radiation Therapy
Radioembolization
Radiofrequency ablation
Registry
Resectability
Resectable Pancreatic Cancer
Resection
Robotic
Ruptured umbilical hernia
serum CEA
simulations
Staged resection
Staging
Subcapsular
Surgery
Surgical resection
Surgiflo
Surveillance
Surveillance
survival
Technology
thromboprophylaxis
TIPS
Training
Tumor distal pancreatectomy
Tumor Margin
tumor suppressor genes
TXP
Value
Vascular Liver Tumours
vascular reconstruction
Vascular-biliary injury
Video Assisted Retroperitoneal Dissection
volume
Walled off Pancreatic Necrosis
Whipple
Whipple at the Splenic Artery
Whipple with Vascular Reconstruction
Whipple’s resection
Women in Surgey
Corporate Partners
If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org
Find out more
